Cancer Prevention News

Mike Schmidt always felt a sense of invincibility as a professional athlete.

Women diagnosed with breast cancer before age 50 were twice as likely to receive a diagnosis of colorectal cancer than their older counterparts, according to the results of a meta-analysis published in Gastrointestinal Endoscopy.

Basic research in immunotherapy and precision medicine remains at the forefront of progress in cancer treatment; however, a strong bipartisan commitment from Congress is needed to continue this progress, according to the seventh annual AACR Cancer Progress Report.

Two scientists from NCI will receive the Lasker-DeBakey Clinical Medical Research Award.

Seventeen public health and medical organizations have urged the American film industry to apply an R rating to all films that include depictions of smoking or other tobacco use.

Mailed outreach invitations for colonoscopy or fecal immunochemical testing both increased the percentage of patients screened for colon cancer over 3 years, but the colonoscopy outreach was more effective, according to the results of a randomized controlled trial.

The FDA has granted 510(k) approval to a first of its kind 2D digital mammography system that allows patients adjust the amount of compression applied to the breast before the mammogram is taken, according to a press release from the FDA.

The FDA has granted 510(k) clearance to add Barrett’s esophagus with low-grade dysplasia to the label of CSA Medical’s truFreeze liquid nitrogen cryotherapy spray system, the company announced.

A new smartphone app called BiliScreen showed promise for pancreatic cancer screening by analyzing signs of jaundice in photos of a user’s eyes.

Epigenomics announced it has begun a post approval study of the blood-based Epi proColon colorectal cancer screening test.